- /
- Supported exchanges
- / US
- / INGN.NASDAQ
Inogen Inc (INGN NASDAQ) stock market data APIs
Inogen Inc Financial Data Overview
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Inogen Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Inogen Inc data using free add-ons & libraries
Get Inogen Inc Fundamental Data
Inogen Inc Fundamental data includes:
- Net Revenue: 347 M
- EBITDA: -7 799 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -0.2133
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Inogen Inc News
New
Inogen Stock Dips Despite Q3 Earnings Beat, Revenues Up Y/Y
Inogen, Inc. INGN incurred an adjusted loss per share of 2 cents for third-quarter 2025, which was narrower than the adjusted loss per share of 11 cents in the year-ago period and the Zacks Consensus ...
Inogen (INGN) Reports Q3 Loss, Misses Revenue Estimates
Inogen (INGN) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.25 per share a year ago. These figures are adjusted...
GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent
GE HealthCare GEHC recently announced that it has signed an exclusive license agreement with medical imaging agents and products manufacturer, Lantheus Holdings, gaining access to the development of t...
Inogen Announces the Appointment of Naga Rameswamy as Chief Technology Officer
GOLETA, Calif., September 25, 2025--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a leading medical technology company offering innovative respiratory products for use in the homecare setting, today a...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.